Sangui Biotech International Inc (SGBI) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sangui Biotech International Inc  (SGBI)


Sangui Biotech International Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sangui Biotech International Inc's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Sangui Biotech International Inc's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter		 (Sep 30 2022)
I. Quarter		 (Jun 30 2022)
IV. Quarter		 (Mar 31 2022)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -2 -2 -1 -1 -1
Return On Investment (TTM) - - - - -
SGBI's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

SGBI Company Profile >> Back to SGBI Roi Comparisons >> See Annual SGBI Return On Investment



Return On Investment SGBI's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Sangui Biotech International Inc's III. Quarter Investments $ -2 Millions SGBI's Balance sheet
Sangui Biotech International Inc's III. Quarter Income $ 0 Millions Quarterly SGBI's Income Statement
SGBI's Income by Division See SGBI's Income by Division


SGBI Annual Return On Investment (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Jun 30 2020)
2020		 (Jun 30 2019)
2019		 (Jun 30 2018)
2018
Total Investments in Millions -1 -1 -1 -1 -1
Y / Y Investment Growth - - - - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SGBI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGBI's Competitors
Subscribers only: Roi for Sangui Biotech International Inc's Suppliers
Subscribers only: Return On Investment for SGBI's Customers

Other Ratios
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Statistics
SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Vertex Pharmaceuticals Inc  22.30 %
Siga Technologies Inc  20.24 %
Innoviva Inc   20.18 %
Pro dex Inc   19.98 %
Chemed Corporation  19.95 %
Edwards Lifesciences Corporation  19.78 %
Corcept Therapeutics Inc  19.07 %
Dr Reddy s Laboratories Limited  19.07 %
Iradimed Corporation  19.01 %
Waters Corporation  18.98 %
Pfizer Inc  18.88 %
West Pharmaceutical Services Inc   18.49 %
Zynex inc   18.06 %
Zoetis Inc   17.90 %
Eli Lilly And Company  17.80 %
Ironwood Pharmaceuticals inc   17.58 %
Tenax Therapeutics Inc   17.51 %
Resmed Inc   17.16 %
Regeneron Pharmaceuticals Inc   16.93 %
Merck and Co Inc   16.68 %
Omeros Corporation  16.14 %
Agilent Technologies inc   15.42 %
3m Company  15.00 %
Amgen Inc   14.94 %
Utah Medical Products Inc  14.76 %
Biogen Inc   14.71 %
Amphastar Pharmaceuticals Inc   14.56 %
Carlisle Companies Incorporated  14.08 %
Hca Healthcare Inc   13.97 %
Escalon Medical Corp   13.92 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.